Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2022-07-30
2024-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tracking Neural Synergies After Stroke.
NCT04805866
Motor rECovery witH eArly imagiNg In STroke
NCT04165616
Muscle Coordination-Based Feedback for Stroke Rehabilitation
NCT06099444
Human-like Robotic Controllers for Enhanced Motor Learning
NCT04578665
Establishing a Prognostic Model for Stroke Recovery
NCT05332652
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Inpatients poststroke
Individuals post acute or subacute that that are inpatients at the Shirley Ryan AbilityLab ages 18-80
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stroke (ischemic subcortical, intermediate level, chronic phase one day to 6 weeks or more from lesion)
* Clinical and radiological evidence supporting the above diagnoses
* Chedoke stroke assessment arm stage and hand stage of 3-6 for the affected limb
* One or more behavioral symptoms possibly linked to the white matter lesion(s)
* Stable medical condition
* Normal hearing and (corrected) vision
* Able to understand and give informed consent
* English speaker
Exclusion Criteria
* Metal in the body (rods, plates, screws, shrapnel, dentures, IUD) or metallic particles in the eye
* Surgical clips in the head or previous neurosurgery
* Any magnetic particles in the body
* Cochlear implants
* Prosthetic heart valves
* Epilepsy or any other type of seizure history
* History of significant head trauma (i.e., extended loss of consciousness, neurological sequelae)
* Significant other disease (heart disease, malignant tumors, mental disorders)
* Significant claustrophobia; Meniere's disease
* Pregnancy, breast feeding
* Medications increasing risk for seizures
* Non prescribed drug use
* Failure to perform the behavioral tasks or neuropsychological evaluation tests
* Prisoners
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shirley Ryan AbilityLab
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jose Pons
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shirley Ryan AbilityLab
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STU00214813
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.